Center's big decision regarding Black Fungus medicines, increase in production of drugs
The Drug Controller General of India (DGCI) has approved five pharma companies to start manufacturing the anti-fungal drug Amphotericin B Liposomal Injection, the demand of which has increased in view of the rise in black fungus infection.
The Drug Controller General of India (DGCI) has approved five pharma companies to start manufacturing the anti-fungal drug Amphotericin B Liposomal Injection, the demand of which has increased in view of the rise in black fungus infection.